Mirum Pharma Inc Live Stock Price Today, Share Analysis and Chart

Name: Mirum Pharmaceuticals Inc: Is Infosys Ltd. worth buying?
Item: Mirum Pharmaceuticals Inc
Rating: 1.26633325
Author: Trendlyne DVM scores

about

Mirum Pharmaceuticals Inc. is a biopharmaceutical company focused on developing and commercializing therapies for rare and orphan diseases. Its main product, Livmarli (maralixibat), is an orally administered IBAT inhibitor approved to treat cholestat...

92.00 0.17 (0.19%)

29.23% Fall from 52W High

653.2K

XNAS Volume

XNAS 21 Sep, 2026 5:30 PM (EDT)

Not Eligible

Expensive Valuation

8.8 / 100

Technically Neutral

41.8 / 100

138

1Yr Price target upside is 50%

14 analysts

Mirum Pharma Inc Live Price Chart

Switch to TradingView

Loading Fundamental data..

Loading data..

Mirum Pharma Inc Live Stock Price Today, Share Analysis and Chart

Mirum Pharmaceuticals Inc. is a biopharmaceutical company focused on developing and commercializing therapies for rare and orphan diseases. Its main product, Livmarli (maralixibat), is an orally administered IBAT inhibitor approved to treat cholestat...

29.23% Fall from 52W High

SWOT Analysis

Mirum Pharma Inc Live Price Chart

Mirum Pharma Inc Live Price Chart